Since we found that RRMS and T1D patients have significantly greater SIRPγlow CD8 T-cells, we asked whether this increased frequency of SIRPγlow T-cells might contribute to increased proinflammatory factors in an autoimmune setting. Here, CD8A is linked to type 1 diabetes mellitus.